Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001315863-25-000610·Esperion Therapeutics, Inc.
Schedule 13G ownership disclosure
ESPERION THERAPEUTICS, INC.
Common Stock, par value $0.001 per share · CUSIP: 29664W105
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Two Seas Capital LP
Shares: 9,954,975 · Class: 5%
- Two Seas Capital GP LLC
Shares: 9,954,975 · Class: 5%
- Sina Toussi
Shares: 9,954,975 · Class: 5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001315863-25-000610
- Form type
- SCHEDULE 13G
- Filer
- Esperion Therapeutics, Inc.
- CIK
- CIK 1434868
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership